Cerence (NASDAQ: CRNC) insider transactions
In the twelve months to 10 November 2026, executives and directors of Cerence reported 7 open-market sales of 423,545 shares ($3.4m) and 1 open-market purchase of 2,000 shares ($14,040), by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 9 October 2026 | Krzanich Brian M | Chief Executive Officer | Open-market sale | −131,715 | $8.26 | 1,568,673 | Form 4 |
| 7 October 2026 | Schanz Nils | EVP Product & Technology | Open-market sale | −52,439 | $8.00 | 290,243 | Form 4 |
| 7 October 2026 | Salinas Jennifer | EVP Chief Admin Officer | Open-market sale | −66,153 | $8.00 | 627,876 | Form 4 |
| 7 October 2026 | Mentz Christian | EVP, Chief Revenue Officer | Open-market sale | −48,923 | $8.00 | 244,551 | Form 4 |
| 7 October 2026 | Krzanich Brian M | Chief Executive Officer | Open-market sale | −21,703 | $8.00 | 1,700,388 | Form 4 |
| 7 October 2026 | Rodriquez Antonio | CFO | Open-market sale | −76,614 | $8.00 | 500,632 | Form 4 |
| 10 August 2026 | Salinas Jennifer | EVP Chief Admin Officer | Open-market sale | −25,998 | $8.83 | 694,029 | Form 4 |
| 15 February 2026 | Rodriquez Antonio | CFO | Open-market purchase | +2,000 | $7.02 | 577,246 | Form 4 |
| 12 February 2026 | Harris Marion | Director | Grant or award | +12,968 | $0.01 | 27,178 | Form 4 |
| 12 February 2026 | Klevorn Marcy S | Director | Grant or award | +12,968 | $0.01 | 35,404 | Form 4 |
| 12 February 2026 | Davis Douglas Lee | Director | Grant or award | +12,968 | $0.01 | 39,544 | Form 4 |
| 12 February 2026 | Budnik Marianne | Director | Grant or award | +12,968 | $0.01 | 60,166 | Form 4 |
| 12 February 2026 | Matus Kristi Ann | Director | Grant or award | +12,968 | $0.01 | 54,737 | Form 4 |
| 9 January 2026 | Rodriquez Antonio | CFO | Grant or award | +131,694 | $12.35 | 575,246 | Form 4 |
| 9 January 2026 | Salinas Jennifer | EVP Chief Admin Officer | Grant or award | +131,694 | $12.35 | 720,027 | Form 4 |
| 9 January 2026 | Schanz Nils | EVP Product & Technology | Grant or award | +87,796 | $12.35 | 342,682 | Form 4 |
| 9 January 2026 | Mentz Christian | EVP, Chief Revenue Officer | Grant or award | +131,694 | $12.35 | 293,474 | Form 4 |
| 9 January 2026 | Krzanich Brian M | Chief Executive Officer | Grant or award | +263,338 | $12.35 | 1,722,091 | Form 4 |
| 21 November 2025 | Schanz Nils | EVP Product & Technology | Grant or award | +49,905 | $10.35 | 254,886 | Form 4 |
| 21 November 2025 | Mentz Christian | EVP, Chief Revenue Officer | Grant or award | +49,905 | $10.35 | 161,780 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Cerence page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.